Revvity Inc

RVTY: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$855.00HnchzxmWwqzjlrzp

Raising Narrow-Moat PerkinElmer's Fair Value Estimate to $144 After Taking a Fresh Look

After taking a fresh look at PerkinElmer, we raised its fair value estimate to $144, from $131 previously, and maintained our narrow moat rating and stable moat trend. PerkinElmer operates under two business segments, Diagnostics and Discovery and Analytical Solutions. Each segment is characterized by the sale of instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industry markets.

Sponsor Center